2025
A promising step forward in infection diagnostics
It’s encouraging to see innovative diagnostic solutions like TriVerity from Inflammatix gaining recognition in the U.S. healthcare landscape. Such advancements are vital in improving outcomes for patients suffering from acute infections, including critical conditions like sepsis. Congratulations to team Inflammatix!
To learn more about TriVerity and its impact, read the full article published in Nature Medicine. You can download the complete PDF below.
Fueling the Future of Diagnostics: Andy Bala’s Pitch at Silicon Valley Demo Day
Andy Bala is excited to share this update regarding Delphine Diagnostic’s pitch to Investor community at Santa Clara CA, on Wednesday, July 16th 2025.
Our Founder & CEO Andy Bala of Delphine Diagnostics Inc pitched for an audience of more than 250 people. It was one of a kind of experiences in the journey of a startup founder.
The audience consisted of VCs, Angel Investors and CEOs of non-profit organizations in addition to management teams, mentors, and coaches of IITStartups, a startup accelerator that provides mentoring and coaching to firms founded by Alumni of IITs in India.
The demo day was a packed event with believers and investors of startup eco system in Silicon Valley. The demo day event was a culmination of 12 weeks of intensive interaction and coaching from IITStarups, accelerator team – who had been in the trenches and learned valuable lessons building successful businesses in Silicon Valley.
The team of mentors and coaches spent enormous time to help the founders community to sharpen business value statements over the period of 12 weeks. At times the critical questions and stimulating recommendations from many coaches were direct, intense, and blunt to drive significant improvements.
We sincerely appreciate Sukhwinder (Sukhi) Lamba (Mentor) and Sohag Desai (Coach), Kishore Lakshminarayan (Chair – IITStartups), Mukesh Goel (President – IITStartups), and to all coach(es) and mentor(s) of IIT Startups who provided valuable feedback throughout the journey of the cohort 13.
The marathon effort and time commitment to IIT community is highly commendable and it resulted in exemplary pitches and a great level of preparedness to handle intense Q&A session(s) that followed the pitch(es).
𝐈𝐭 𝐰𝐚𝐬 𝐚𝐧 𝐡𝐨𝐧𝐨𝐫 𝐭𝐨 𝐩𝐢𝐭𝐜𝐡 𝐚𝐥𝐨𝐧𝐠𝐬𝐢𝐝𝐞 𝐜𝐨𝐡𝐨𝐫𝐭𝟏𝟑 𝐟𝐨𝐮𝐧𝐝𝐞𝐫𝐬 – Anantha Bangalore Ashfaq Rasheed Karthik Krishnamurthy @Manish Kulkarni @Rajesh S Ajay Nyamati Satyajeet Prasad @Manoj Paul Pramin Pradeep Sid Raman Ajay Dankar Pranil Dasika Divya Manjari
Delphine Diagnostics Receives Maternal and Infant Health R & D Award Grant from the New Jersey Commission on Science Innovation and Technology (NJ CSIT)
Princeton, NJ. March 5, 2025
New Jersey – Delphine Diagnostics, a pioneering company in medical diagnostics, is honored to announce that it has been awarded the Maternal and Infant Health Award on Tuesday, March 5, 2025. This recognition highlights the company’s dedication to developing faster and more accurate diagnostic solutions to improve healthcare outcomes for pregnant women and infants.
The Delphine Diagnostics team extends its deepest gratitude to First Lady Tammy Murphy, NJEDA CEO Tim Sullivan, MIHIA Chair Lisa Asare, and CSIT Executive Director Judith Sheft for their support and for championing advancements in maternal and infant health.
“At Delphine Diagnostics, we are committed to revolutionizing medical diagnostics to provide safer, more joyful, and sacred experiences for expecting mothers and infants,” said Andy Bala, CEO at Delphine Diagnostics. “This award reinforces our mission to improve early detection and patient outcomes through cutting-edge technology.”
With a team of industry experts and healthcare innovators, Delphine Diagnostics continues to develop next-generation diagnostic tools aimed at enhancing maternal healthcare and addressing critical challenges in perinatal care.
For more information about the CSIT Award, please click here.
